Status:
COMPLETED
HKI-272 Ketoconazole Drug Interaction Study
Lead Sponsor:
Puma Biotechnology, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
To investigate a potential pharmacokinetic drug interaction between HKI-272 and ketoconazole when co-administered.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG.
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00380328
Start Date
October 1 2006
End Date
November 1 2006
Last Update
May 14 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.